Latest Health in the People's Republic of China Stories
Healthcare IT market report evaluates global market with respect to the product market; analyzes geography; forecasting revenues and trends. (PRWEB) May 18, 2013 The “World Healthcare IT Market: Trends & Forecast (2010 – 2015)” analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, & Rest of the world. Browse 89 market data tables 20 Figures and in-depth TOC on "Healthcare IT Market"...
JERSEY CITY, N.J., May 15, 2013 /PRNewswire/ -- Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN) ("Aoxing Pharma"), a specialty pharmaceutical company focusing on research, development, manufacturing, and distribution of narcotic, pain-management, and addiction treatment pharmaceuticals, today announced its financial and operational results for the three and nine month periods ended March 31, 2013. Complete financial results can be found in the Quarterly Report on Form 10-Q filed...
Lucintel profiles leaders in generic drugs industry: global market expected to reach US $335.8 Billion in 2017 Irving, TX (PRWEB) May 14, 2013 Top companies are making strategic acquisitions to expand their global footprint, together with taking advantage of established business and expertise gained through the acquired company. The global generic drugs industry experienced average growth over the last five years and is expected to reach approximately US $335.8 billion in 2017. Lucintel,...
FREMONT, Calif., May 14, 2013 /PRNewswire/ -- Zosano Pharma, Inc., a privately held pharmaceutical company developing products based on its novel transdermal delivery technology, announced today a key addition to its executive team with the appointment of Nandan Oza as the company's Chief Operations Officer. In this position, Mr. Oza will guide the company's efforts in manufacturing, quality and engineering - vital activities to enable the company to accelerate the development of its...
TAINAN, Taiwan, May 10, 2013 /PRNewswire/ -- ScinoPharm Taiwan Ltd. (TSE: 1789.TW) and Coland Holdings Ltd. (TSE: 4144.TW) announced today that they have formed a strategic alliance to develop a series of generic oncological drugs for Mainland China. Several Active Pharmaceutical Ingredients (APIs) have been initially selected for development and future sales as injectable formulation products from the list of ScinoPharm-developed APIs. This will allow the companies to compete within...
AMSTERDAM, May 7, 2013 /PRNewswire/ -- Co-located events P-MEC/ICSE/BioPh/InnoPack/LABWorld are helping to build improved partnerships and drive GMP standards across the region CPhI announces that CPhI China [http://www.cphi-china.com ], an event organised by UBM Live and UBM Sinoexpo, is returning to the Shanghai New International Expo Center (25-27 June 2013, Shanghai) for the 13th consecutive year - with an increased scale, more informative exhibition and regional...
Patient monitoring systems with advanced features, especially wireless or remote capability, are among the fastest-growing medical devices. This report provides complete market sizes and revenue breakouts for the important segments of the advanced monitoring market. Rockville, MD (PRWEB) May 03, 2013 Philips and Medtronic are the leading companies in remote patient monitoring, according to Kalorama Information. The healthcare market research firm says that these companies are able to...
NEW YORK, May 2, 2013 /PRNewswire/ -- Ohr Pharmaceutical Inc. (OTCQB: OHRP), a pharmaceutical company focused on the development of novel therapeutics for unmet medical needs, today announced the appointment of Thomas M. Riedhammer, Ph.D., to its Board of Directors. Dr. Riedhammer has over 35 years of ophthalmic industry experience, working for large and small pharmaceutical companies engaged in drug development through commercialization. "We are pleased to have brought on someone...
ALISO VIEJO, Calif., May 1, 2013 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) will report financial results for the quarter ended March 31, 2013 after market close on Wednesday May 8, 2013. The company will conduct a conference call and an audio webcast at 1:30 pm Pacific Time (4:30 pm Eastern Time) on the same day. Conference Call Information:Domestic callers: 1 (877) 703 6106International callers: +1 (857) 244-7305Passcode: 62763985 Webcast information: Visit...
NANJING, China, April 27, 2013 /PRNewswire/ -- Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, announced today that the Company filed its annual report on Form 20-F for the year ended December 31, 2012 with the Securities and Exchange Commission on April 26, 2013, U.S. Eastern Time. The annual report can be...
